Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Trial details
- Registry ID
- NCT07863193
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)NCT07863193 | SGMT | Phase 3 | Recruiting | 2027-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |